Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase

Journal of Medicinal Chemistry

Volumn 46, Issue 9, 2003, Pages 1661-1669

  Hah, Jung Mi ^a   Martásek, Pavel ^b   Roman, Linda J ^b   Silverman, Richard B ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; DIPEPTIDE; GUANIDINE DERIVATIVE; N [4 AMINO 5 [2 (2 AMINOETHYL)PHENYLAMINO]PENTYL] N' NITROGUANIDINE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL BOND; ENDOTHELIUM; LIPOPHILICITY; MODEL; NERVE CELL; SYNTHESIS;

ANIMALS; CATTLE; DIPEPTIDES; ENZYME INHIBITORS; ISOENZYMES; MICE; MOLECULAR MIMICRY; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RATS; RECOMBINANT PROTEINS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0344088452     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0202932     Document Type: Article

References (34)

1. Kerwin, J. F., Jr.; Lancaster, J. R. Jr. Nitric Oxide; A New Paradigm for Second Messengers. Med. Res. Rev. 1994, 14, 23-74.
2. Forstermann, U.; Pollock, J. S.; Schmidt, H. H. H. W.; Heller, M.; Murad, F. Calmodulin Dependent Endothelium-Derived Relaxing Factor/Nitric Oxide Synthase Activity is Present in the Particulate and Cytosolic Fractions of Bovine Aortic Endothelial Cells. Prot. Natl. Acad. Sci. U.S.A. 1991, 88, 1788-1792.
3. Schmidt, H. H. H. W.; Walter, U. NO at Work. Cell 1994, 78, 919-925.
4. MacMicking, J.; Xie, Q. W.; Nathan, C. Nitric Oxide and Macrophage Function. Annu. Rev. Immunol. 1997, 15, 323-350.
5. Marletta, M. A. Approaches Toward Selective Inhibition of Nitric Oxide Synthase. J. Med. Chem. 1994, 37, 1899-1907.
6. Moncada, S.; Higgs, E. A. Molecular Mechanism and Therapeutic Strategies related to Nitric Oxide. FASEB J. 1995, 9, 1319-1330.
7. Dawson, V. L.; Dawson, T. M.; London, E. D.; Bredt, D. S.; Snyder, S. H. Nitric Oxide Mediates Glutamate Neurotoxicity in Primary Cortical Cultures. Proc. Natl. Acad. Sci. USA 1991, 88, 6368-6371.
8. (b) Mayer, B.; Hemmens, B. Biosynthesis and Action of Nitric Oxide in Mammalian Cells. Trends Biochem. Sci. 1997, 22, 477-481.
9. Nelson, R. J.; Demas, G. E.; Huang, P. L.; Fishman, M. C.; Dawson, V. L.; Dawson, T. M.; Snyder, S. H. Behavioral Abnormalities in Male Mice Lacking Neuronal Nitric Oxide Synthase. Nature 1995, 378, 383-386.
10. Crow, J. P.; Beckman, J. S. The Role of Peroxynitrite in Nitric Oxide-Mediated Toxicity. Curr. Top. Microbiol. Immunol. 1995, 196, 57-73.
11. Kilbourn, R. G.; Jubran, A.; Gross, S. S.; Griffith, O. W.; Levi, R.; Adams, J.; Lodato, R. F. Reversal of Endotoxin-Mediated Shock by NG-Methyl-L-Arginine, an Inhibitor of Nitric Oxide Synthesis. Biochem. Biophys. Res. Commun. 1990, 172, 1132-1138.
12. Babu, B. R.; Griffith, O. W. Design of Isoform-Selective Inhibitors of nitric oxide synthase. Curr. Opin. Chem. Biol. 1998, 2, 491-500.
13. Silverman, R. B.; Huang, H.; Marletta, M. A.; Martesek, P. Selective Inhibition of Neuronal Nitric Oxide Synthase by Nω-Nitroarginine- and Phenylalanine-Containing Dipeptides and Dipeptide Esters. J. Med. Chem. 1997, 40, 2813-2817.
14. Huang, H; Martasek, P.; Roman, L. J.; Masters, B. S. S.; Silverman, R. B. Nω- Nitroarginine-Containing Dipeptide Amides. Potent and Highly Selective Inhibitors of Neuronal Nitric Oxide Synthase. J. Med. Chem. 1999, 42, 3147-3153.
15. Furfine, E. S.; Harmon, M. F.; Paith, J. E.; Garvey, E. P. Selective Inhibitor of Constitutive Nitric Oxide Synthase by NG-Nitroarginine. Biochemistry 1993, 32, 8512-8517.
16. Thiemermann, C.; Mustafa, M.; Mester, P. A.; Mitchell, J. A.; Hecker, M.; Vane, J. R. Inhibition of the release of endothelium-derived relaxing factor in vitro and in vivo by dipeptides containing NG-nitro-L-arginine. Br. J. Pharmacol. 1991, 104, 31-38.
17. Hecker, M.; Walsh, D. T.; Vane, J. R. On the substrate specificity of nitric oxide synthase. FEBS Lett. 1991, 294, 221-224.
18. Fischmann, T. O.; Hruza, A.; Niu, X. D.; Fossetta, J. D.; Lunn, C. A.; Dolphin, E.; Prongay, A. J.; Reichert, P.; Lundell, D. J.; Narula, S. K.; Weber, P. C. Structural Characterization of nitric oxide synthase isoforms reveals striking active-site conservation. Nature Struct. Biol. 1999, 6, 233-242.
19. Crane, B. R.; Arval, A. S.; Gachuhui, R.; Wu, C.; Ghosh, D. K.; Getzoff, E. D.; Stuehr, D. J.; Tainer, J. A. The structure of nitric oxide synthase oxygenase domain and inhibitor complexes. Science 1997, 278, 425-431.
20. Tierney, D. L.; Huang, H.; Martasek, P.; Roman, L. J.; Silverman, R. B.; Hoffman, B. M. ENDOR Spectroscopic Evidence for the Geometry of Binding of retro-inverso-Nω- Nitroarginine-Containing Dipeptide Amides to Neuronal Nitric Oxide Synthase. J. Am. Chem. Soc. 2000, 122, 7869-7875.
21. Hah, J.-M.; Roman, L. J.; Martasek, P.; Silverman, R. B. Reduced Amide Bond Peptidomimetics. N- (4S)-[4-Amino-5-(2-amino-alkylamino)-pentyl]-N′-nitroguanidines, Potent and Highly Selective Inhibitors of Neuronal Nitric Oxide Synthase. J. Med. Chem. 2001, 44, 2667-2670.
22. Tamura, S. Y.; Semple, J. E.; Ardecky, R. J. Novel and General Method for the Preparation of Peptidyl Argininals. Tetrahedron Lett. 1996, 37, 4109-4112.
23. Ito, A.; Takahashi, R.; Baba, Y. A New Method to Synthesize α-Aminoaldehydes. Chem. Pharm. Bull. 1975, 23, 3081-3087.
24. Peng, L.; Goeldner, M. Synthesis and Characterization of Photolabile Chlorine Precursors as Reversible Inhibitors of Cholinesterases: Release of Choline in the Microsecond Time Range. J. Org. Chem. 1996, 61, 185-191.
25. Bellamy, F. D.; Ou, K. Selective Reduction of Aromatic Nitro Compounds with Stannous Chloride in Non Acidic and Non Aqueous Medium. Tetrahedron Lett. 1984, 25, 839-842.
26. Krapcho, A. P.; Kuell, C. S. N-tert-Butoxycarbonyl-α,ω-Alkanediamines from α,ω-Alkanediamines. Synth. Commun. 1990, 20, 2559-2564.
27. Dixon, M. Determination of enzyme-inhibitor constants. Biochem. J. 1953, 55, 170-171.
28. Cornish-Bowden, A. Simple graphical method for determining the inhibition constants of mixed, uncompetitive, and noncompetitive inhibitors. Biochem. J. 1974, 137, 143-144.
29. Hevel, J. M.; White, K. A.; Marletta, M. Purification of the Inducible Murine Macrophage Nitric Oxide Synthase. J. Biol. Chem. 1991, 266, 22789-22791.
30. Roman, L. J.; Sheta, E. A; Martasek, P.; Gross, S. S.; Liu, Q.; Masters, B. S. S. High-Level Expression of Functional Rat Neuronal Nitric Oxide Synthase in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 8428-8432.
31. Gerber, N. C.; Montelloano, P. R. Neuronal nitric oxide synthase. Expression in Escherichia coli, irreversible inhibition by phenyldiazene, and active site topology. J. Biol. Chem. 1995, 270, 17991-17996.
32. Martasek, P.; Liu, Q.; Roman, L. J; Gross, S. S.; Sessa, W. C.; Masters, B. S. S. Characterization of Bovine Endothelial Nitric Oxide Synthase Expressed in Escherichia coli. Biochem. Biophys. Res. Commun. 1996, 219, 359-365.
33. Hevel, J. M.; Marletta, M. Nitric Oxide Synthase Assays. Methods Enzymol. 1994, 133, 250-258.
34. Segel, I. H. Enzyme Kinetics; John Wiley and Sons: New York, 1975; p 105.